8-bromo cyclic adenosine monophosphate has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, C; Connor, P; Menon, KM; Pearl, ML; Roberts, JA; Talavera, F | 1 |
| Jimbo, T; Kato, Y; Kawana, T; Shan, L | 1 |
2 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Endometrial Neoplasms
| Article | Year |
|---|---|
cAMP and PMA enhance the effects of IGF-I in the proliferation of endometrial adenocarcinoma cell line HEC-1-A by acting at the G1 phase of the cell cycle.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenocarcinoma; Colforsin; Culture Media, Serum-Free; Cyclic AMP; Diglycerides; Drug Interactions; Endometrial Neoplasms; Female; Flow Cytometry; Fluorescent Antibody Technique; G1 Phase; Humans; Insulin-Like Growth Factor I; Interphase; Phorbol Esters; Proliferating Cell Nuclear Antigen; Resting Phase, Cell Cycle; Signal Transduction; Thymidine; Tumor Cells, Cultured | 1995 |
[Effect of phorbol ester on tissue-type plasminogen activator (t-PA) secretion in endometrial carcinoma cell line in vitro].
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cholera Toxin; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Phorbol Esters; Protein Biosynthesis; Protein Kinase C; Tetradecanoylphorbol Acetate; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1994 |